Drug factory · FDA FEI 3007836611
Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.
No. 6 Yangshan Road, Jinshanqiao Economic Zone, Xuzhou, China
Problems found, fixed voluntarily at FDA's last inspection, Sep 8, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2023: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Heparin | Makes it, tests it, packages it and labels it | Gland Pharma Limited | 68083-136 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Sep 8, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.